These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. Kamijo A; Kimura K; Sugaya T; Yamanouchi M; Hikawa A; Hirano N; Hirata Y; Goto A; Omata M J Lab Clin Med; 2004 Jan; 143(1):23-30. PubMed ID: 14749682 [TBL] [Abstract][Full Text] [Related]
28. The effect of chronic kidney disease on the urine proteome in the domestic cat (Felis catus). Ferlizza E; Campos A; Neagu A; Cuoghi A; Bellei E; Monari E; Dondi F; Almeida AM; Isani G Vet J; 2015 Apr; 204(1):73-81. PubMed ID: 25726445 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs. Takashima S; Nagamori Y; Ohata K; Oikawa T; Sugaya T; Kobatake Y; Nishii N J Vet Med Sci; 2021 Sep; 83(9):1465-1471. PubMed ID: 34526412 [TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy. Xie Y; Xu W; Wang Q; Shao X; Ni Z; Mou S Biomark Med; 2014; 8(4):543-56. PubMed ID: 24796620 [TBL] [Abstract][Full Text] [Related]
31. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547 [TBL] [Abstract][Full Text] [Related]
32. Urinary liver-type fatty acid-binding protein predicts recovery from acute kidney injury. Wang L; Xue J; Chen C; Zhang Z; Deng Z; Sun Z; Xing C Clin Nephrol; 2015 Nov; 84(5):255-61. PubMed ID: 26396099 [TBL] [Abstract][Full Text] [Related]
33. Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate. Summers S; Quimby JM; Phillips RK; Stockman J; Isaiah A; Lidbury JA; Steiner JM; Suchodolski J J Vet Intern Med; 2020 Jan; 34(1):206-215. PubMed ID: 31693251 [TBL] [Abstract][Full Text] [Related]
34. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan]. Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707 [TBL] [Abstract][Full Text] [Related]
35. Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis. Torigoe K; Muta K; Tsuji K; Yamashita A; Ota Y; Kitamura M; Mukae H; Nishino T Med Sci Monit; 2020 Dec; 26():e928236. PubMed ID: 33347426 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats. Ghys LF; Paepe D; Lefebvre HP; Reynolds BS; Croubels S; Meyer E; Delanghe JR; Daminet S J Vet Intern Med; 2016 Jul; 30(4):1074-82. PubMed ID: 27461722 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD. Matsui K; Kamijo-Ikemori A; Imai N; Sugaya T; Yasuda T; Tatsunami S; Toyama T; Shimizu M; Furuichi K; Wada T; Shibagaki Y; Kimura K Clin Exp Nephrol; 2016 Apr; 20(2):195-203. PubMed ID: 26189083 [TBL] [Abstract][Full Text] [Related]
38. [L-type fatty acid binding protein (L-FABP) and kidney disease]. Kamijo-Ikemori A; Sugaya T; Kimura K Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492 [TBL] [Abstract][Full Text] [Related]
39. Neutrophil Gelatinase-Associated Lipocalin in Cats with Naturally Occurring Chronic Kidney Disease. Wang IC; Hsu WL; Wu PH; Yin HY; Tsai HJ; Lee YJ J Vet Intern Med; 2017 Jan; 31(1):102-108. PubMed ID: 28019047 [TBL] [Abstract][Full Text] [Related]